KBC Group’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$83K Hold
7,212
﹤0.01% 1430
2025
Q4
$104K Buy
7,212
+2,332
+48% +$40.3K ﹤0.01% 1247
2025
Q3
$92K Hold
4,880
﹤0.01% 1318
2025
Q2
$105K Sell
4,880
-2,227
-31% -$33.1K ﹤0.01% 1171
2025
Q1
$93K Hold
7,107
﹤0.01% 1522
2024
Q4
$96K Buy
7,107
+2,555
+56% +$41.1K ﹤0.01% 1588
2024
Q3
$97K Buy
4,552
+1,328
+41% +$23.9K ﹤0.01% 1306
2024
Q2
$51K Hold
3,224
﹤0.01% 1602
2024
Q1
$48K Buy
+3,224
New +$44.2K ﹤0.01% 1580

Other funds holding OSCR

KBC Group's OSCR Position: Q1 2026 in Review

KBC Group held its Oscar Health (OSCR) position steady in Q1 2026 at 7,212 shares worth $83K. The position accounts for ﹤0.01% of the portfolio, ranked #1430.

KBC Group first reported a position in OSCR in Q1 2024 and has held it in 9 quarters since. The position peaked at $105K in Q2 2025. 331 funds tracked by Wall St. Rank hold OSCR as of Q1 2026.

  • KBC Group held 7,212 shares of Oscar Health worth $83K as of Q1 2026.
  • KBC Group left its Oscar Health share count unchanged in Q1 2026.
  • Oscar Health made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1430 holding.
  • KBC Group first reported a position in Oscar Health in Q1 2024 and has held it in 9 quarters since.
  • KBC Group's Oscar Health position peaked at $105K in Q2 2025.
  • 331 funds tracked by Wall St. Rank held Oscar Health as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.